Slowly Progressive, Angiotensin II–Independent Glomerulosclerosis in Human (Pro)renin Receptor–Transgenic Rats
Open Access
- 1 June 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 18 (6), 1789-1795
- https://doi.org/10.1681/asn.2006091062
Abstract
For defining the pathogenic effects of the (pro)renin receptor–transgenic rat, strains that overexpressed the human receptor were generated. Although transgenic rats were normotensive and euglycemic and had a renal angiotensin II (AngII) level that was comparable to that of wild-type rats, transgenic rats developed proteinuria with aging and significant glomerulosclerosis at 28 wk of age. In kidneys of 28-wk-old transgenic rats, mitogen-activated protein kinases (MAPK) were activated without recognizable tyrosine phosphorylation of the EGF receptor, and expression of TGF-β1 was enhanced. In vivo infusion of the (pro)renin receptor blocker peptide (formerly handle region decoy peptide) significantly inhibited the development of glomerulosclerosis, proteinuria, MAPK activation, and TGF-β1 expression in the kidneys, but the angiotensin-converting enzyme inhibitor did not attenuate these changes despite a significant decrease in the renal AngII level. In addition, recombinant rat prorenin stimulated MAPK activation in the human receptor–expressed cultured cells, but human receptor was unable to evoke the enzyme activity of rat prorenin. Thus, human (pro)renin receptor elicits slowly progressive nephropathy by AngII-independent MAPK activation in rats. This study clearly provided in vivo evidence for the AngII-independent MAPK activation by human (pro)renin receptor and induction of glomerulosclerosis with increased TGF-β1 expression.Keywords
This publication has 18 references indexed in Scilit:
- Contribution of Nonproteolytically Activated Prorenin in Glomeruli to Hypertensive Renal DamageJournal of the American Society of Nephrology, 2006
- Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic ratsKidney International, 2006
- Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic HypertensionHypertension, 2006
- Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanismsKidney International, 2006
- Novel Integrative Approaches to the Identification of Candidate Genes in HypertensionHypertension, 2006
- ERK-dependent Signaling Pathway and Transcriptional Factor Ets-1 Regulate Matrix Metalloproteinase-9 Production in Transforming Growth Factor-β1 Stimulated Glomerular PodocytesCellular Physiology and Biochemistry, 2005
- TGF-β1stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent processAmerican Journal of Physiology-Cell Physiology, 2005
- Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic ActivationPublished by Elsevier BV ,2003
- The Dominant Role of the Prosegment of Prorenin in Determining the Rate of Activation by Acid or Trypsin: Studies with Molecular ChimerasBiochemical and Biophysical Research Communications, 2000
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991